Advances in using chitosan-based nanoparticles for in vitro and in vivo drug and gene delivery

Bibliography

• Rouget C. Des substances amylacees dans le tissu des animeaux, specialement les articules (chitine). Comp Rend 1859;48:792-5
   Google Scholar
• Kumar MN, Muzzarelli RA, Muzzarelli C, Chitosan chemistry and pharmaceutical perspectives. Chem Rev 2004;104:6017-84
   PubMed Web of Science ®Google Scholar
• Pasha S, Gupta K. Various drug delivery approaches to the central nervous system. Expert Opin Drug Deliv 2010;7:113-35
   PubMed Web of Science ®Google Scholar
• Mintzer MA, Simanek EE. Nonviral vectors for gene delivery. Chem Rev 2009;109:259-302
   PubMed Web of Science ®Google Scholar
• Mishra N, Goyal AK, Khatri K, Biodegradable polymer based particulate carrier(s) for the delivery of proteins and peptides. Antiinflamm Antiallergy Agents Med Chem 2008;7:240-51
   Google Scholar
• Hejazi R, Amiji M. Chitosan-based gastrointestinal delivery systems. J Control Release 2003;89:151-65
   PubMed Web of Science ®Google Scholar
• Agnihotri SA, Mallikarjuna NN, Aminabhavi TM. Recent advances on chitosan-based micro- and nanoparticles in drug delivery. J Control Release 2004;100:5-28
   PubMed Web of Science ®Google Scholar
• Arai K, Kinumaki T, Fujita T. Toxicity of chitosan. Bull Tokai Reg Fish Lab 1968;56:89-94
   Google Scholar
• Richardson SCW, Kolbe HJV, Duncan R. Potential of low molecular mass chitosan as a DNA delivery system: biocompatibility, body distribution and ability to complex and protect DNA. Int J Pharm 1999;178:231-43
   PubMed Web of Science ®Google Scholar
• Mao S, Shuai X, Unger F, The depolymerization of chitosan: effects on physicochemical and biological properties. Int J Pharm 2004;281:45-54
   PubMed Web of Science ®Google Scholar
• Carreno-Gomez B, Duncan R. Evaluation Of the biological properties of soluble chitosan and chitosan microspheres. Int J Pharm 1997;148:231-40
   Web of Science ®Google Scholar
• Huang M, Khor E, Lim LY. Uptake and cytotoxicity of chitosan molecules and nanoparticles: effects of molecular weight and degree of deacetylation. Pharm Res 2004;21:344-53
   PubMed Web of Science ®Google Scholar
• Muzzarelli RA. Human enzymatic activities related to the therapeutic administration of chitin derivatives. Cell Mol Life Sci 1997;53:131-40
   PubMed Web of Science ®Google Scholar
• Chandy T, Sharma CP. Chitosan – as a biomaterial. Biomater Artif Cells Artif Organs 1990;18:1-24
   PubMed Web of Science ®Google Scholar
• Tomihata K, Ikada Y. In vitro and in vivo degradation of films of chitin and its deacetylated derivatives. Biomaterials 1997;18:567-75
   PubMed Web of Science ®Google Scholar
• Qian F, Cui FY, Ding JY, Chitosan graft copolymer nanoparticles for oral protein drug delivery: preparation and characterization. Biomacromolecules 2006;7:2722-7
   PubMed Web of Science ®Google Scholar
• Qin CQ, Li HR, Xiao Q, Water-solubility of chitosan and its antimicrobial activity. Carbohydr Polym 2006;63:367-74
   Web of Science ®Google Scholar
• Kurita K, Kamiya M, Nishimura SI. Solubilization of a rigid polysaccharide – controlled partial N-acetylation of chitosan to develop solubility. Carbohydr Polym 1991;16:83-92
   Web of Science ®Google Scholar
• Bonferoni MC, Sandri G, Rossi S, Chitosan and its salts for mucosal and transmucosal delivery. Expert Opin Drug Deliv 2009;6:923-39
   PubMed Web of Science ®Google Scholar
• Hagens WI, Oomen AG, de Jong WH, What do we (need to) know about the kinetic properties of nanoparticles in the body? Regul Toxicol Pharmacol 2007;49:217-29
   PubMed Web of Science ®Google Scholar
• Gaumet M, Vargas A, Gurny R, Delie F. Nanoparticles for drug delivery: the need for precision in reporting particle size parameters. Eur J Pharm Biopharm 2008;69:1-9
   PubMed Web of Science ®Google Scholar
• Brigger I, Dubernet C, Couvreur P. Nanoparticles in cancer therapy and diagnosis. Adv Drug Deliv Rev 2002;54:631-51
   PubMed Web of Science ®Google Scholar
• Brannon-Peppas L, Blanchette JO. Nanoparticle and targeted systems for cancer therapy. Adv Drug Deliv Rev 2004;56:1649-59
   PubMed Web of Science ®Google Scholar
• Wang YT, Chen Y, Hong Y. Clinical prospect of chitosan as a drug carrier and gene carrier. J Clin Rehab Tissue Eng Res 2008;12:1895-8
   Google Scholar
• Dong L, Gao S, Diao H, Galactosylated low molecular weight chitosan as a carrier delivering oligonucleotides to Kupffer cells instead of hepatocytes in vivo. J Biomed Mater Res A 2008;84:777-84
   PubMed Web of Science ®Google Scholar
• Kim TH, Jin H, Kim HW, Mannosylated chitosan nanoparticle-based cytokine gene therapy suppressed cancer growth in BALB/c mice bearing CT-26 carcinoma cells. Mol Cancer Ther 2006;5:1723-32
   PubMed Web of Science ®Google Scholar
• Issa MM, Koping-Hoggard M, Tommeraas K, Targeted gene delivery with trisaccharide-substituted chitosan oligomers in vitro and after lung administration in vivo. J Control Release 2006;115:103-12
   PubMed Web of Science ®Google Scholar
• Fernandes JC, Wang H, Jreyssaty C, Bone-protective effects of nonviral gene therapy with folate-chitosan DNA nanoparticle containing interleukin-1 receptor antagonist gene in rats with adjuvant-induced arthritis. Mol Ther 2008;16:1243-51
   PubMed Web of Science ®Google Scholar
• Dufes C, Muller JM, Couet W, Anticancer drug delivery with transferrin targeted polymeric chitosan vesicles. Pharm Res 2004;21:101-7
   PubMed Web of Science ®Google Scholar
• Park JH, Kwon SG, Nam JO, Self-assembled nanoparticles based on glycol chitosan bearing 5 beta-cholanic acid for RGD peptide delivery. J Control Release 2004;95:579-88
   PubMed Web of Science ®Google Scholar
• Kim JH, Kim YS, Park K, Self-assembled glycol chitosan nanoparticles for the sustained and prolonged delivery of antiangiogenic small peptide drugs in cancer therapy. Biomaterials 2008;29:1920-30
   PubMed Web of Science ®Google Scholar
• Chuang CY, Don TM, Chiu WY. Synthesis of chitosan-based thermo- and pH-responsive porous nanoparticles by temperature-dependent self-assembly method and their application in drug release. J Polym Sci Part A 2009;47:5126-36
   Web of Science ®Google Scholar
• Kim DH, Kim KN, Kim KM, Lee YK. Targeting to carcinoma cells with chitosan- and starch-coated magnetic nanoparticles for magnetic hyperthermia. J Biomed Mater Res A 2009;88:1-11
   PubMed Web of Science ®Google Scholar
• Huang M, Ma Z, Khor E, Lim LY. Uptake of FITC-chitosan nanoparticles by A549 cells. Pharm Res 2002;19:1488-94
   PubMed Web of Science ®Google Scholar
• Ishii T, Okahata Y, Sato T. Mechanism of cell transfection with plasmid/chitosan complexes. Biochim Biophys Acta 2001;1514:51-64
   PubMed Web of Science ®Google Scholar
• Akinc A, Thomas M, Klibanov AM, Langer R. Exploring polyethylenimine-mediated DNA transfection and the proton sponge hypothesis. J Gene Med 2005;7:657-63
   PubMed Web of Science ®Google Scholar
• Smith AM, Duan H, Mohs AM, Nie S. Bioconjugated quantum dots for in vivo molecular and cellular imaging. Adv Drug Deliv Rev 2008;60:1226-40
   PubMed Web of Science ®Google Scholar
• Sandros MG, Behrendt M, Maysinger D, Tabrizian M. InGaP@ZnS-enriched chitosan nanoparticles: a versatile fluorescent probe for deep-tissue imaging. Adv Funct Mater 2007;17:3724-30
   Web of Science ®Google Scholar
• Yuan Q, Venkatasubramanian R, Hein S, Misra RD. A stimulus-responsive magnetic nanoparticle drug carrier: magnetite encapsulated by chitosan-grafted-copolymer. Acta Biomater 2008;4:1024-37
   PubMed Web of Science ®Google Scholar
• Li L, Chen D, Zhang Y, Magnetic and fluorescent multifunctional chitosan nanoparticles as a smart drug delivery system. Nanotechnology 2007;18 art. no. 405102
   Web of Science ®Google Scholar
• Bhattarai SR, Remant BKC, Aryal S, Hydrophobically modified chitosan/gold nanoparticles for DNA delivery. J Nanoparticle Res 2008;10:151-62
   Web of Science ®Google Scholar
• Sashiwa H, Yajima H, Aiba S. Synthesis of a chitosan-dendrimer hybrid and its biodegradation. Biomacromolecules 2003;4:1244-9
   PubMed Web of Science ®Google Scholar
• Lee KY, Kwon IC, Kim YH, Preparation of chitosan self-aggregates as a gene delivery system. J Control Release 1998;51:213-20
   PubMed Web of Science ®Google Scholar
• Yu H, Chen X, Lu T, Poly(l-lysine)-graft-chitosan copolymers: synthesis, characterization, and gene transfection effect. Biomacromolecules 2007;8:1425-35
   PubMed Web of Science ®Google Scholar
• Park KM, Bae JW, Joung YK, Nanoaggregate of thermosensitive chitosan-pluronic for sustained release of hydrophobic drug. Colloids Surf B Biointerfaces 2008;63:1-6
   PubMed Web of Science ®Google Scholar
• Yu H, Wang W, Chen X, Synthesis and characterization of the biodegradable polycaprolactone-graft-chitosan amphiphilic copolymers. Biopolymers 2006;83:233-42
   PubMed Web of Science ®Google Scholar
• Douglas KL, Tabrizian M. Effect of experimental parameters on the formation of alginate-chitosan nanoparticles and evaluation of their potential application as DNA carrier. J Biomater Sci Polym Ed 2005;16:43-56
   PubMed Web of Science ®Google Scholar
• Douglas KL, Piccirillo CA, Tabrizian M. Cell line-dependent internalization pathways and intracellular trafficking determine transfection efficiency of nanoparticle vectors. Eur J Pharm Biopharm 2008;68:676-87
   PubMed Web of Science ®Google Scholar
• Douglas KL, Piecirillo CA, Tabrizian M. Effects of alginate inclusion on the vector properties of chitosan-based nanoparticles. J Control Release 2006;115:354-61
   PubMed Web of Science ®Google Scholar
• Duceppe N, Tabrizian M. Factors influencing the transfection efficiency of ultra low molecular weight chitosan/hyaluronic acid nanoparticles. Biomaterials 2009;30:2625-31
   PubMed Web of Science ®Google Scholar
• Sarmento B, Martins S, Ribeiro A, Development and comparison of different nanoparticulate polyelectrolyte complexes as insulin carriers. Int J Pept Res Ther 2006;12:131-8
   Web of Science ®Google Scholar
• Tiyaboonchai W, Limpeanchob N. Formulation and characterization of amphotericin B-chitosan-dextran sulfate nanoparticles. Int J Pharm 2007;329:142-9
   PubMed Web of Science ®Google Scholar
• Zheng YL, Yang W, Wang CC, Nanoparticles based on the complex of chitosan and polyaspartic acid sodium salt: preparation, characterization and the use for 5-fluorouracil delivery. Eur J Pharm Biopharm 2007;67:621-31
   PubMed Web of Science ®Google Scholar
• Nafee N, Taetz S, Schneider M, Chitosan-coated PLGA nanoparticles for DNA/RNA delivery: effect of the formulation parameters on complexation and transfection of antisense oligonucleotides. Nanomed Nanotechnol Biol Med 2007;3:173-83
   PubMed Web of Science ®Google Scholar
• Guan XP, Quan DP, Liao KR, Preparation and characterization of cationic chitosan-modified poly(d,l-lactide-co-glycolide) copolymer nanospheres as DNA carriers. J Biomater Appl 2008;22:353-71
   PubMed Web of Science ®Google Scholar
• Liu C, Tan Y, Liu C, Preparations, characterizations and applications of chitosan-based nanoparticles. J Ocean Univ China 2007;6:237-43
   Google Scholar
• Nagamoto T, Hattori Y, Takayama K, Maitani Y. Novel chitosan particles and chitosan-coated emulsions inducing immune response via intranasal vaccine delivery. Pharm Res 2004;21:671-4
   PubMed Web of Science ®Google Scholar
• Prego C, Fabre M, Torres D, Alonso MJ. Efficacy and mechanism of action of chitosan nanocapsules for oral peptide delivery. Pharm Res 2006;23:549-56
   PubMed Web of Science ®Google Scholar
• Bowman K, Leong KW. Chitosan nanoparticles for oral drug and gene delivery. Int J Nanomed 2006;1:117-28
   PubMed Web of Science ®Google Scholar
• Fernandez-Urrusuno R, Calvo P, Remunan-Lopez C, Enhancement of nasal absorption of insulin using chitosan nanoparticles. Pharm Res 1999;16:1576-81
   PubMed Web of Science ®Google Scholar
• Pan Y, Li YJ, Zhao HY, Bioadhesive polysaccharide in protein delivery system: chitosan nanoparticles improve the intestinal absorption of insulin in vivo. Int J Pharm 2002;249:139-47
   PubMed Web of Science ®Google Scholar
• Huang X, Du YZ, Yuan H, Hu FQ. Preparation and pharmacodynamics of low-molecular-weight chitosan nanoparticles containing insulin. Carbohydr Polym 2009;76:368-73
   Web of Science ®Google Scholar
• Zengshuan M, Yeoh HH, Lim LY. Formulation pH modulates the interaction of insulin with chitosan nanoparticles. J Pharm Sci 2002;91:1396-404
   PubMed Web of Science ®Google Scholar
• Cui F, Qian F, Zhao Z, Preparation, characterization, and oral delivery of insulin loaded carboxylated chitosan grafted poly(methyl methacrylate) nanoparticles. Biomacromolecules 2009;10:1253-8
   PubMed Web of Science ®Google Scholar
• Wang X, Zheng C, Wu Z, Chitosan-NAC nanoparticles as a vehicle for nasal absorption enhancement of insulin. J Biomed Mater Res B Appl Biomater 2009;88:150-61
   PubMed Web of Science ®Google Scholar
• Jo HG, Min KH, Nam TH, Prolonged antidiabetic effect of zinc-crystallized insulin loaded glycol chitosan nanoparticles in type 1 diabetic rats. Arch Pharm Res 2008;31:918-23
   PubMed Web of Science ®Google Scholar
• Yin L, Ding J, He C, Drug permeability and mucoadhesion properties of thiolated trimethyl chitosan nanoparticles in oral insulin delivery. Biomaterials 2009;30:5691-700
   PubMed Web of Science ®Google Scholar
• Zhang X, Zhang H, Wu Z, Nasal absorption enhancement of insulin using PEG-grafted chitosan nanoparticles. Eur J Pharm Biopharm 2008;68:526-34
   PubMed Web of Science ®Google Scholar
• Parveen S, Sahoo SK. Polymeric nanoparticles for cancer therapy. J Drug Target 2008;16:108-23
   PubMed Web of Science ®Google Scholar
• Qi L, Xu Z, Chen M. In vitro and in vivo suppression of hepatocellular carcinoma growth by chitosan nanoparticles. Eur J Cancer 2007;43:184-93
   PubMed Web of Science ®Google Scholar
• Greish K. Enhanced permeability and retention of macromolecular drugs in solid tumors: a royal gate for targeted anticancer nanomedicines. J Drug Target 2007;15:457-64
   PubMed Web of Science ®Google Scholar
• Agnihotri SA, Aminabhavi TM. Chitosan nanoparticles for prolonged delivery of timolol maleate. Drug Dev Ind Pharm 2007;33:1254-62
   PubMed Web of Science ®Google Scholar
• Kao HJ, Lin HR, Lo YL, Yu SP. Characterization of pilocarpine-loaded chitosan/carbopol nanoparticles. J Pharm Pharmacol 2006;58:179-86
   PubMed Web of Science ®Google Scholar
• Papadimitriou S, Bikiaris D, Avgoustakis K, Chitosan nanoparticles loaded with dorzolamide and pramipexole. Carbohydr Polym 2008;73:44-54
   Web of Science ®Google Scholar
• Mistry A, Stolnik S, Illum L. Nanoparticles for direct nose-to-brain delivery of drugs. Int J Pharm 2009;379:146-57
   PubMed Web of Science ®Google Scholar
• Wang X, Chi N, Tang X. Preparation of estradiol chitosan nanoparticles for improving nasal absorption and brain targeting. Eur J Pharm Biopharm 2008;70:735-40
   PubMed Web of Science ®Google Scholar
• Kumar M, Pathak K, Misra A. Formulation and characterization of nanoemulsion-based drug delivery system of risperidone. Drug Dev Ind Pharm 2009;35:387-95
   PubMed Web of Science ®Google Scholar
• Motwani SK, Chopra S, Talegaonkar S, Chitosan-sodium alginate nanoparticles as submicroscopic reservoirs for ocular delivery: formulation, optimisation and in vitro characterisation. Eur J Pharm Biopharm 2008;68:513-25
   PubMed Web of Science ®Google Scholar
• Bourlais CL, Acar L, Zia H, Ophthalmic drug delivery systems – recent advances. Prog Retin Eye Res 1998;17:33-58
   PubMed Web of Science ®Google Scholar
• Jain D, Banerjee R. Comparison of ciprofloxacin hydrochloride-loaded protein, lipid, and chitosan nanoparticles for drug delivery. J Biomed Mater Res B Appl Biomater 2008;86:105-12
   PubMed Web of Science ®Google Scholar
• Huang M, Khor E, Lim LY. Uptake and cytotoxicity of chitosan molecules and nanoparticles: effects of molecular weight and degree of deacetylation. Pharma Res 2004;21:344-53
   Google Scholar
• Kiang T, Wen J, Lim HW, Leong KW. The effect of the degree of chitosan deacetylation on the efficiency of gene transfection. Biomaterials 2004;25:5293-301
   PubMed Web of Science ®Google Scholar
• Liu X, Howard KA, Dong M, The influence of polymeric properties on chitosan/siRNA nanoparticle formulation and gene silencing. Biomaterials 2007;28:1280-8
   PubMed Web of Science ®Google Scholar
• Lavertu M, Methot S, Tran-Khanh N, Buschmann MD. High efficiency gene transfer using chitosan/DNA nanoparticles with specific combinations of molecular weight and degree of deacetylation. Biomaterials 2006;27:4815-24
   PubMed Web of Science ®Google Scholar
• Koping-Hoggard M, Varum KM, Issa M, Improved chitosan-mediated gene delivery based on easily dissociated chitosan polyplexes of highly defined chitosan oligomers. Gene Ther 2004;11:1441-52
   PubMed Web of Science ®Google Scholar
• Zhao X, Yu SB, Wu FL, Transfection of primary chondrocytes using chitosan-pEGFP nanoparticles. J Control Release 2006;112:223-8
   PubMed Web of Science ®Google Scholar
• Sato T, Ishii T, Okahata Y. In vitro gene delivery mediated by chitosan. Effect of pH, serum, and molecular mass of chitosan on the transfection efficiency. Biomaterials 2001;22:2075-80
   PubMed Web of Science ®Google Scholar
• Huang YC, Vieira A, Huang KL, Pulmonary inflammation caused by chitosan microparticles. J Biomed Mater Res A 2005;75A:283-7
   Web of Science ®Google Scholar
• Xu X, Capito RM, Spector M. Plasmid size influences chitosan nanoparticle mediated gene transfer to chondrocytes. J Biomed Mater Res A 2008;84:1038-48
   PubMedGoogle Scholar
• Conner SD, Schmid SL. Regulated portals of entry into the cell. Nature 2003;422:37-44
   PubMed Web of Science ®Google Scholar
• Yang XR, Zong L, Yuan XY. Chitosan nanoparticles as gene vector: effect of particle size on transfection efficiency. Yao Xue Xue Bao 2007;42:774-9
   PubMedGoogle Scholar
• Huang M, Fong CW, Khor E, Lim LY. Transfection efficiency of chitosan vectors: effect of polymer molecular weight and degree of deacetylation. J Control Release 2005;106:391-406
   PubMed Web of Science ®Google Scholar
• Lavertu M, Methot S, Tran-Khanh N, Buschmann MD. High efficiency gene transfer using chitosan/DNA nanoparticles with specific combinations of molecular weight and degree of deacetylation. Biomaterials 2006;27:4815-24
   PubMed Web of Science ®Google Scholar
• Erbacher P, Zou SM, Bettinger T, Chitosan-based vector/DNA complexes for gene delivery: biophysical characteristics and transfection ability. Pharm Res 1998;15:1332-9
   PubMed Web of Science ®Google Scholar
• Shcharbin D, Pedziwiatr E, Blasiak J, Bryszewska M. How to study dendriplexes II: transfection and cytotoxicity. J Control Release 2010;141:110-27
   PubMed Web of Science ®Google Scholar
• Corsi K, Chellat F, Yahia L, Fernandes JC. Mesenchymal stem cells, MG63 and HEK293 transfection using chitosan-DNA nanoparticles. Biomaterials 2003;24:1255-64
   PubMed Web of Science ®Google Scholar
• Pouton CW, Lucas P, Thomas BJ, Polycation-DNA complexes for gene delivery: a comparison of the biopharmaceutical properties of cationic polypeptides and cationic lipids. J Control Release 1998;53:289-99
   PubMed Web of Science ®Google Scholar
• Kumar M, Behera AK, Lockey RF, Intranasal gene transfer by chitosan-DNA nanospheres protects BALB/c mice against acute respiratory syncytial virus infection. Hum Gene Ther 2002;13:1415-25
   PubMed Web of Science ®Google Scholar
• Koping-Hoggard M, Mel'nikova YS, Varum KM, Relationship between the physical shape and the efficiency of oligomeric chitosan as a gene delivery system in vitro and in vivo. J Gene Med 2003;5:130-41
   PubMed Web of Science ®Google Scholar
• Roy K, Mao HQ, Huang SK, Leong KW. Oral gene delivery with chitosan – DNA nanoparticles generates immunologic protection in a murine model of peanut allergy. Nat Med 1999;5:387-91
   PubMed Web of Science ®Google Scholar
• Zhang X, Yu C, Xushi, Direct chitosan-mediated gene delivery to the rabbit knee joints in vitro and in vivo. Biochem Biophys Res Commun 2006;341:202-8
   PubMed Web of Science ®Google Scholar
• Zheng F, Shi XW, Yang GF, Chitosan nanoparticle as gene therapy vector via gastrointestinal mucosa administration: results of an in vitro and in vivo study. Life Sci 2007;80:388-96
   PubMed Web of Science ®Google Scholar
• Calvo P, Remunan-Lopez C, Vila-Jato JL, Novel hydrophilic chitosan-polyethylene oxide nanoparticles as protein carriers. J Appl Polym Sci 1997;63:125-32
   Web of Science ®Google Scholar
• Heuking S, Iannitelli A, Di SA, Borchard G. Toll-like receptor-2 agonist functionalized biopolymer for mucosal vaccination. Int J Pharm 2009;381:97-105
   PubMed Web of Science ®Google Scholar
• Amin M, Jaafari MR, Tafaghodi M. Impact of chitosan coating of anionic liposomes on clearance rate, mucosal and systemic immune responses following nasal administration in rabbits. Colloids Surf B Biointerfaces 2009;74:225-9
   PubMed Web of Science ®Google Scholar
• Uddin AN, Bejugam NK, Gayakwad SG, Oral delivery of gastro-resistant microencapsulated typhoid vaccine. J Drug Target 2009;17:553-60
   PubMed Web of Science ®Google Scholar
• Yang X, Zhang Q, Wang Y, Self-aggregated nanoparticles from methoxy poly(ethylene glycol)-modified chitosan: synthesis; characterization; aggregation and methotrexate release in vitro. Colloids Surf B Biointerfaces 2008;61:125-31
   PubMed Web of Science ®Google Scholar
• Cha J, Won BL, Chong RP, Preparation and characterization of cisplatin-incorporated chitosan hydrogels, microparticles, and nanoparticles. Macromol Res 2006;14:573-8
   Web of Science ®Google Scholar
• Janes KA, Fresneau MP, Marazuela A, Chitosan nanoparticles as delivery systems for doxorubicin. J Control Release 2001;73:255-67
   PubMed Web of Science ®Google Scholar
• Wang YS, Liu LR, Jiang Q, Zhang QQ. Self-aggregated nanoparticles of cholesterol-modified chitosan conjugate as a novel carrier of epirubicin. Eur Polym J 2007;43:43-51
   Web of Science ®Google Scholar
• Bilensoy E, Sarisozen C, Esendagli G, Intravesical cationic nanoparticles of chitosan and polycaprolactone for the delivery of mitomycin C to bladder tumors. Int J Pharm 2009;371:170-6
   PubMed Web of Science ®Google Scholar
• Hwang HY, Kim IS, Kwon IC, Kim YH. Tumor targetability and antitumor effect of docetaxel-loaded hydrophobically modified glycol chitosan nanoparticles. J Control Release 2008;128:23-31
   PubMed Web of Science ®Google Scholar
• Min KH, Park K, Kim YS, Hydrophobically modified glycol chitosan nanoparticles-encapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapy. J Control Release 2008;127:208-18
   PubMed Web of Science ®Google Scholar
• Zhao X, Yu SB, Wu FL, Transfection of primary chondrocytes using chitosan-pEGFP nanoparticles. J Control Release 2006;112:223-8
   PubMed Web of Science ®Google Scholar
• Sato T, Ishii T, Okahata Y. In vitro gene delivery mediated by chitosan. effect of pH, serum, and molecular mass of chitosan on the transfection efficiency. Biomaterials 2001;22:2075-80
   PubMed Web of Science ®Google Scholar
• Koping-Hoggard M, Mel'nikova YS, Varum KM, Relationship between the physical shape and the efficiency of oligomeric chitosan as a gene delivery system in vitro and in vivo. J Gene Med 2003;5:130-41
   PubMed Web of Science ®Google Scholar
• Yang XR, Zong L, Yuan XY. Chitosan nanoparticles as gene vector: effect of particle size on transfection efficiency. Yao Xue Xue Bao 2007;42:774-9
   PubMedGoogle Scholar
• Xu X, Capito RM, Spector M. Plasmid size influences chitosan nanoparticle mediated gene transfer to chondrocytes. J Biomed Mater Res A 2008;84:1038-48
   PubMedGoogle Scholar
• Badawi AA, El-Laithy HM, El Qidra RK, Chitosan based nanocarriers for indomethacin ocular delivery. Arch Pharm Res 2008;31:1040-9
   PubMed Web of Science ®Google Scholar
• Tokumitsu H, Hiratsuka J, Sakurai Y, Gadolinium neutron-capture therapy using novel gadopentetic acid–chitosan complex nanoparticles: in vivo growth suppression of experimental melanoma solid tumor. Cancer Lett 2000;150:177-82
   PubMed Web of Science ®Google Scholar
• Zhang C, Qu G, Sun Y, Biological evaluation of N-octyl-O-sulfate chitosan as a new nano-carrier of intravenous drugs. Eur J Pharm Sci 2008;33:415-23
   PubMed Web of Science ®Google Scholar